Precision fluid and vasoactive drug therapy for critically ill patients

Seth R. Bauer, Rochelle M. Gellatly, Brian L. Erstad

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Abstract

There are several clinical practice guidelines concerning the use of fluid and vasoactive drug therapies in critically ill adult patients, but the recommendations in these guidelines are often based on low-quality evidence. Further, some were compiled prior to the publication of landmark clinical trials, particularly in the comparison of balanced crystalloid and normal saline. An important consideration in the treatment of critically ill patients is the application of precision medicine to provide the most effective care to groups of patients most likely to benefit from the therapy. Although not currently widely integrated into these practice guidelines, the utility of precision medicine in critical illness is a recognized research priority for fluid and vasoactive therapy management. The purpose of this narrative review was to illustrate the evaluation and challenges of providing precision fluid and vasoactive therapies to adult critically ill patients. The review includes a discussion of important investigations published after the release of currently available clinical practice guidelines to provide insight into how recommendations and research priorities may change future guidelines and bedside care for critically ill patients.

Original languageEnglish (US)
Pages (from-to)1182-1193
Number of pages12
JournalPharmacotherapy
Volume43
Issue number11
DOIs
StatePublished - Nov 2023

Keywords

  • albumin
  • balanced crystalloids
  • fluid therapy
  • normal saline
  • precision medicine
  • vasoactive drugs

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Precision fluid and vasoactive drug therapy for critically ill patients'. Together they form a unique fingerprint.

Cite this